218 related articles for article (PubMed ID: 35850313)
1. Optimizing component formula suppresses lung cancer by blocking DTL-mediated PDCD4 ubiquitination to regulate the MAPK/JNK pathway.
Fan Q; Lu Q; Wang G; Zhu W; Teng L; Chen W; Bi L
J Ethnopharmacol; 2022 Dec; 299():115546. PubMed ID: 35850313
[TBL] [Abstract][Full Text] [Related]
2. DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation.
Cui H; Wang Q; Lei Z; Feng M; Zhao Z; Wang Y; Wei G
J Exp Clin Cancer Res; 2019 Aug; 38(1):350. PubMed ID: 31409387
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
[TBL] [Abstract][Full Text] [Related]
4. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.
Yang HS; Matthews CP; Clair T; Wang Q; Baker AR; Li CC; Tan TH; Colburn NH
Mol Cell Biol; 2006 Feb; 26(4):1297-306. PubMed ID: 16449643
[TBL] [Abstract][Full Text] [Related]
5. Green tea-derived theabrownin suppresses human non-small cell lung carcinoma in xenograft model through activation of not only p53 signaling but also MAPK/JNK signaling pathway.
Xiao X; Guo L; Dai W; Yan B; Zhang J; Yuan Q; Zhou L; Shan L; Efferth T
J Ethnopharmacol; 2022 Jun; 291():115167. PubMed ID: 35271947
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma.
Zhen Y; Liu Z; Yang H; Yu X; Wu Q; Hua S; Long X; Jiang Q; Song Y; Cheng C; Wang H; Zhao M; Fu Q; Lyu X; Chen Y; Fan Y; Liu Y; Li X; Fang W
Cell Death Dis; 2013 Oct; 4(10):e872. PubMed ID: 24157866
[TBL] [Abstract][Full Text] [Related]
7. Inhibition effect of oxyepiberberine isolated from Coptis chinensis franch. On non-small cell lung cancer based on a network pharmacology approach and experimental validation.
Zhang Y; Yao Y; Fu Y; Yuan Z; Wu X; Wang T; Hong Z; Yang Y; Wu H
J Ethnopharmacol; 2021 Oct; 278():114267. PubMed ID: 34087401
[TBL] [Abstract][Full Text] [Related]
8. Feedback regulations of miR-21 and MAPKs via Pdcd4 and Spry1 are involved in arsenite-induced cell malignant transformation.
Shen L; Ling M; Li Y; Xu Y; Zhou Y; Ye J; Pang Y; Zhao Y; Jiang R; Zhang J; Liu Q
PLoS One; 2013; 8(3):e57652. PubMed ID: 23469214
[TBL] [Abstract][Full Text] [Related]
9. Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc.
Wang Q; Zhang Y; Yang HS
Biochim Biophys Acta; 2012 Oct; 1823(10):1807-14. PubMed ID: 22801218
[TBL] [Abstract][Full Text] [Related]
10. [Puerarin Inhibits the Proliferation,Invasion,and Migration of Non-small Cell Lung Cancer Cells through Regulating miR-490/Denticleless E3 Ubiquitin Protein Ligase].
Zhang YX; Zhang ZZ; Zhao LG; Zhao LL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Feb; 44(1):91-101. PubMed ID: 35300770
[TBL] [Abstract][Full Text] [Related]
11. Disclosing targets and pharmacological mechanisms of total bioflavonoids extracted from Selaginella doederleinii against non-small cell lung cancer by combination of network pharmacology and proteomics.
Xu D; Wang X; Huang D; Chen B; Lin X; Liu A; Huang J
J Ethnopharmacol; 2022 Mar; 286():114836. PubMed ID: 34793885
[TBL] [Abstract][Full Text] [Related]
12. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS
Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D
J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003
[TBL] [Abstract][Full Text] [Related]
13. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
[TBL] [Abstract][Full Text] [Related]
15. Shikonin reactivates TSGs GADD45B and PPP3CC to block NSCLC cell proliferation and migration through JNK/P38/MAPK signaling pathways.
Zhao Y; Wu D; Fu Z; Liu W; Yao Y; Liang Y
BMC Complement Med Ther; 2024 Jan; 24(1):10. PubMed ID: 38167059
[TBL] [Abstract][Full Text] [Related]
16. XBP1s promotes the development of lung adenocarcinoma via the p‑JNK MAPK pathway.
Jiang H; Jiang Q; He Y; Li X; Xu Y; Liu X
Int J Mol Med; 2022 Mar; 49(3):. PubMed ID: 35059734
[TBL] [Abstract][Full Text] [Related]
17. Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene.
Jiang LP; He CY; Zhu ZT
Oncotarget; 2017 Apr; 8(14):23675-23689. PubMed ID: 28423589
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
[TBL] [Abstract][Full Text] [Related]
19. Network Pharmacology and Molecular Docking Study on the Potential Mechanism of Yi-Qi-Huo-Xue-Tong-Luo Formula in Treating Diabetic Peripheral Neuropathy.
Lin Y; Shen C; Wang F; Fang Z; Shen G
J Diabetes Res; 2021; 2021():9941791. PubMed ID: 34159207
[TBL] [Abstract][Full Text] [Related]
20. Network Pharmacology Analysis and Experiments Validation of the Inhibitory Effect of JianPi Fu Recipe on Colorectal Cancer LoVo Cells Metastasis and Growth.
Lu X; Wu X; Jing L; Tao L; Zhang Y; Huang R; Zhang G; Ren J
Evid Based Complement Alternat Med; 2020; 2020():4517483. PubMed ID: 32774415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]